Colomer Bosch, Ramon ramon.colomer@uam.es
Publications
- Articles 257
- Books 4
- Book chapters 3
- Conferences 91
- Working papers 1
- Technical reports 4
- Research projects 1
- Supervised theses 9
- Patent or software license 0
Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)
- Albanell, J.
- Andreu, X.
- Calasanz, M.J.
- Concha, Á.
- Corominas, J.M.
- García-Caballero, T.
- López, J.A.
- López-Ríos, F.
- Cajal, S.R.
- Vera-Sempere, F.J.
- Colomer, R.
- Martín, M.
- Alba, E.
- González-Martín, A.
- Llombart, A.
- Lluch, A.
- Palacios, J.
Clinical & Translational Oncology (p. 363-375) - 1/6/2009
10.1007/s12094-009-0370-6 View at source
- ISSN 1699048X
- ISSN/ISBN 1699-048X
HER2 (erb B-2)-targeted effects of the ?-3 polyunsaturated. Fatty acid ?-linolenic acid (ALA; 18:3n-3) in breast cancer cells: The ?fat features? of the ?Mediterranean diet? as an ?anti-HER2 cocktail?
- Menéndez, J.A.
- Vázquez-Martín, A.
- Ropero, S.
- Colomer, R.
- Lupu, R.
- Trueta, J.
Clinical & Translational Oncology (p. 812-20) - 1/12/2006
10.1007/s12094-006-0137-2 View at source
- ISSN 1699048X
- ISSN/ISBN 1699-048X
- Dialnet
- iMarina
HER2 evaluation in gastric carcinoma: A consensus study by the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)
- López-Ríos, F.
- Concha, Á.
- Corominas, J.M.
- García-Caballero, T.
- García-García, E.
- Iglesias, M.
- López, J.A.
- Ramón, S.
- Cajal, null
- Rojo, F.
- Palacios, J.
- Vera-Sempere, F.
- Aranda, E.
- Colomer, R.
- García-Alfonso, P.
- Garrido, P.
- Rivera, F.
- Gómez-Martín, C.
Revista Espanola De Patologia (p. 32-48) - 1/1/2011
Editor: Ediciones Doyma, S.L.
10.1016/j.patol.2011.02.004 View at source
- ISSN 1988561X
- ISSN/ISBN 1988-561X
Herceptin: From the bench to the clinic
- Colomer, R
- Shamon, LA
- Tsai, MS
- Lupu, R;
Cancer Investigation (p. 49-56) - 3/4/2001
10.1081/cnv-100000074 View at source
- ISSN 07357907
High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: A confirmatory prospective study
- Colomer, Ramon
- Llombart-Cussac, Antonio
- Lloveras, Belen
- Ramos, Manuel
- Mayordomo, Jose I.
- Fernandez, Roberto
- Tusquets, Ignasi
- Gil, Miguel
- Barnadas, Agusti
- Constenla, Manuel
- Gilabert, Montserrat
- Alba, Emilio;
Cancer (p. 2178-2185) - 15/11/2007
10.1002/cncr.23043 View at source
- ISSN 0008543X
High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor?positive metastatic breast cancer: A …
- Ramon Colomer
- Antonio Llombart?Cussac
- Belen Lloveras
- Manuel Ramos
- Jose I Mayordomo
- Roberto Fernandez
- Ignasi Tusquets
- Miguel Gil
- Agustí Barnadas
- Manuel Constenla
- Montserrat Gilabert
- Emilio Alba
Cancer: Interdisciplinary International Journal Of The American Cancer Society (p. 2178-2185) - 1/1/2007
- iMarina
High-Dose Mitoxantrone and Cyclophosphamide Without Stem Cell Support in Patients with High-Risk and Advanced Breast Carcinoma - A Phase II Multicentric Trial
- Jose Luis Pérez?Gracia
- Ramon Colomer
- Emilio Esteban
- Ramón Barceló
- Manuel Benavides
- Javier Puertas
- Alberto Arcediano
- María Victoria Tornamira
- Vicente Valentín
- Alberto Muñoz
- Hernán Cortés?Funes
- Javier Hornedo
Cancer (p. 2508-2516) - 15/11/2001
10.1002/1097-0142(20011115)92:10<2508::aid-cncr1601>3.0.co;2-# View at source
- ISSN 0008543X
- iMarina
- iMarina
High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial
- Perez-Gracia, JL
- Colomer, R
- Ruiz-Casado, A
- Arcediano, A
- Tornamira, MV
- Gomez-Martin, C
- Valentin, V
- Mendiola, C
- Cortes-Funes, H
- Hornedo, J;
Bone Marrow Transplantation (p. 117-123) - 1/1/2001
10.1038/sj.bmt.1702751 View at source
- ISSN 02683369
IMPROVING TREATMENT OF CHEMOTHERAPY-INDUCED NEUTROPENIC FEVER BY ADMINISTRATION OF COLONY-STIMULATING FACTORS
- JI Mayordomo
- F Rivera
- MT Diaz-Puente
- P Lianes
- R Colomer
- E Lopez-brea
- L Paz-Ares
- R Hitt
- I García-Ribas
- R Cubedo
- S Alonso
- H Cortés-Funes
Jnci-Journal Of The National Cancer Institute (p. 803-808) - 7/6/1995
10.1093/jnci/87.11.803 View at source
- ISSN 00278874
- iMarina
- iMarina
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients
- Rogado, J.
- Sánchez-Torres, J.M.
- Romero-Laorden, N.
- Ballesteros, A.I.
- Pacheco-Barcia, V.
- Ramos-Leví, A.
- Arranz, R.
- Lorenzo, A.
- Gullón, P.
- Donnay, O.
- Adrados, M.
- Costas, P.
- Aspa, J.
- Alfranca, A.
- Mondéjar, R.
- Colomer, R.
European Journal Of Cancer (p. 21-27) - 1/3/2019
Editor: Elsevier Ltd
10.1016/j.ejca.2018.10.014 View at source
- ISSN 09598049
- ISSN/ISBN 1879-0852
Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study
- J Albanell
- E Ciruelos
- R Colomer
- J De la Haba
- M Martin
- De Salas-Cansado
- B Munoz-Molina
- C Tournier
- P Thuresson
- W Schleich
1/1/2015
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- MD Fenor De La Maza
- V Pacheco-Barcia
- JM Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondejar
- O Donnay
- B Obispo
- R Colomer
- JM Sanchez-Torres
1/1/2017
- iMarina
Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …
- Chau Dang
- Michael S Ewer
- Suzette Delaloge
- Jean-Marc Ferrero
- Mark Verrill
- Ramon Colomer
- Claudia Vieira
- Luis de la Cruz Merino
- Jennifer Lucas
- Theresa L Werner
- Hannah Douthwaite
- Denise Bradley
- Maeve Waldron-Lynch
- Jennifer Eng-Wong
- Sandra M Swain
1/1/2018
- iMarina
Fatty acid metabolism in cancer cell survival: A new anti-cancer target
- Porta, Rut
- Colomer, Ramon
- Puig, Teresa;
Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011
- iMarina
Medicina de precisión en oncología: Éxitos y perspectivas bioéticas
- Ramón Colomer Bosch
Bioética Y Cáncer (p. 17-26) - 1/1/2020
- iMarina
18F-misonidazole PET (FMISO-PET) monitors vascular normalization (VN) and predicts benefit from antiangiogenic treatment plus chemotherapy in pancreas cancer
- Mondejar, Tamara
- Hernadez-Agudo, Elena
- Soto-Montenegro, Marisa
- Megias, Diego
- Cebrian, David
- Sanchez, Jesus
- Mulero, Francisca
- Colomer, Ramon
- Hidalgo, Manuel
- Desco, Manuel
- Quintela-Fandino, Miguel;
Cancer Research - 1/1/2015
10.1158/1538-7445.am2015-1493 View at source
- ISSN 00085472
A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature
- Gomez, H
- Colomer, R
- Casttellanos, D
- CortesFunes, H;
European Journal Of Cancer (p. 1205-1205) - 1/1/1997
- ISSN 09598049
- iMarina
ADDING PERTUZUMAB IN NEOADJUVANT TREATMENT OF PATIENTS WITH HER2(+) BREAST CANCER IN SPAIN: A COST OFFSETS STUDY
- Albanell, J.
- Ciruelos, E.
- Colomer, R.
- De la Haba, J.
- Martin, M.
- De Salas-Cansado, M.
- Munoz-Molina, B.
- Tournier, C.
- Thuresson, P.
- Schleich, W.;MORSE Hlth Technology Assessment
- Global Pricing Market Access
Basic & Clinical Pharmacology & Toxicology (p. 42-42) - 1/1/2015
- ISSN 17427835
- iMarina
An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations
- B Leyland-Jones
- R Colomer
- M Trudeau
- A Wardley
- J Latreille
- D Cameron
- R Cubedo
- N Al-Sakaff
- JE Charoin
- J Cortés
European Journal Of Cancer, Supplement (p. 215-215) - 1/1/2007
10.1016/s1359-6349(07)70867-4 View at source
- ISSN 13596349
- iMarina
- iMarina
Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
- J Rogado
- Fenor De La Maza
- V Pacheco-Barcia
- J Serra
- P Toquero
- B Vera
- A Ballesteros
- R Mondéjar
- O Donnay
- B Obispo
- R Colomer
- J Sánchez-Torres
Journal Of Thoracic Oncology (p. S2107-S2108) - 1/1/2017
- ISSN 15560864
- iMarina
Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
- Rogado Revuelta, Jacobo
- Romero-Laorden, Nuria
- Sanchez Torres, Jose Miguel
- Pacheco-Barcia, Vilma
- Ballesteros, Anabel
- Maria Ramos-Levi, Ana
- Arranz, Reyes
- Lorenzo, Alicia
- Gullon, Pedro
- Garrido Garcia, Ana
- Maria Serra, Jose
- Donnay, Olga
- Adrados, Magdalena
- Costas, Pablo
- Aspa, Javier
- Alfranca, Arantza
- Fenor De la Maza, Maria Dolores
- Mondejar, Rebeca
- Colomer, Ramon;
Journal Of Clinical Oncology - 1/1/2019
- ISSN 0732183X
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with metastatic breast cancer receiving chemotherapy
- Marangolo, M.
- Lang, I.
- Beato, C.
- Colomer, R.
- Ukarma, L.;
European Journal Of Cancer, Supplement (p. 388-388) - 1/1/2005
- ISSN 13596349
- iMarina
Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …
- M Marangolo
- I Lang
- C Beato
- R Colomer
- L Ukarma
(p. 388-388) - 1/1/2005
- iMarina
CA 15.3 - A NEW MARKER FOR BREAST-CANCER (BC) PRELIMINARY-RESULTS
- SOLE, LA
- COLOMER, R
- NAVARRO, M
- ENCABO, G
- RUIBAL, A;
Anticancer Research (p. 601-602) - 1/1/1985
- ISSN 02507005
- iMarina
CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN
- Ciruelos, E.
- Alba, E.
- Lopez, R.
- Lluch, A.
- Martin, M.
- Arroyo, I
- Navarro, B.
- Carcedo, D.
- Colomer, R.
- Albanell, J.;
Value In Health (p. S18-S18) - 1/1/2018
10.1016/j.jval.2018.09.102 View at source
- ISSN 10983015
[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]
- Sanchez-Munoz, A
- Gravalos Castro, C
- Colomer Bosch, R
- Garcia Velasco, A
- Garcia, J P
- Cortes-Funes, H
Revista Clinica Espanola (p. 597-598) - 1/1/2003
- ISSN 15781860
- iMarina
A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer
- Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R
Clinical Breast Cancer (p. 286-91) - 1/1/2003
10.3816/cbc.2003.n.034 View at source
- ISSN 15268209
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
- Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators
Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020
- ISSN 0732183X
- iMarina
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.
- Hitt, R
- Paz-Ares, L
- Hidalgo, M
- Colomer, R
- Brandariz, A
- Pena, M
- Alvarez-Vicent, J
- Hornedo, J
- Cortes-Funes, H;
Seminars In Oncology (p. S19-20) - 1/12/1997
- ISSN 00937754
- iMarina
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization
- Arranz, R.
- García-Alfonso, P.
- Sobrino, P.
- Zamora, P.
- Carrión, R.
- García-Laraña, J.
- Pérez, G.
- López, J.
- Lavilla, E.
- Lozano, M.
- Rayón, C.
- Colomer, R.
- González Barón, M.
- Flores, E.
- Pérez-Manga, G.
- Fernández-Rañada, J.M.
Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998
Editor: American Society of Clinical Oncology
10.1200/jco.1998.16.4.1538 View at source
- ISSN 0732183X
- ISSN/ISBN 0732-183X
- Dialnet
- iMarina
Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís
1/1/2016
- iMarina
Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo
1/1/2003
- iMarina
Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín
1/1/2007
- iMarina
El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Javier Abel Menéndez Menéndez (Director)
- Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo
1/1/2016
- iMarina
Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia
1/1/2004
- iMarina
Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director)
- Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz
1/1/2002
- iMarina
Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater
1/1/1996
- iMarina
Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas
- Colomer Bosch, Ramon (Autor o Coautor)
- Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez
1/1/2001
- iMarina
This researcher has no patents or software licenses.
Researcher profiles
-
ORCID
-
Publons
-
Scopus Author ID
-
Dialnet id